Hong Xin
Executive Director Johnson & Johnson
Hong Xin, PhD, MBA is Senior Director of Oncology External Innovation at Johnson & Johnson Innovative Medicine, where she leads early stage oncology innovation and partnerships for East North America collaborating with BD, JJDC Corporate venture, DPDS and Boston Innovation center. Prior to this role, she led the Search & Evaluation effort focusing on Oncology at Boston Innovation Center after spending five years with JNJ’s Asia Pacific Innovation Center where she led the external innovation for Korea across therapeutic areas and business sectors. Prior to her role in external innovation, she led earlier drug discovery programs at Janssen R& D across various therapeutic areas.
Seminars
Wednesday 9th September 2026
Pharma Icebreaker Panel Discussion: Targeted Oncology Biologics
8:00 am
- Understanding what it takes for pharma to invest. What are the current budgetary considerations within pharma?
- How is pharma assessing novel technologies, and where do they place within portfolios?
- What feels differentiated in a crowded space? From pharma’s perspective, what will make something best-in-class?
